Jiang Xu

2.3k total citations
60 papers, 1.9k citations indexed

About

Jiang Xu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Jiang Xu has authored 60 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Cardiology and Cardiovascular Medicine, 24 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Jiang Xu's work include Renin-Angiotensin System Studies (17 papers), Cardiac Fibrosis and Remodeling (13 papers) and Receptor Mechanisms and Signaling (10 papers). Jiang Xu is often cited by papers focused on Renin-Angiotensin System Studies (17 papers), Cardiac Fibrosis and Remodeling (13 papers) and Receptor Mechanisms and Signaling (10 papers). Jiang Xu collaborates with scholars based in United States, China and Canada. Jiang Xu's co-authors include Oscar A. Carretero, Xiao-Ping Yang, Yun-He Liu, Fang Yang, Edward G. Shesely, Nour-Eddine Rhaleb, Edward L. Peterson, Xiaoping Yang, Alissa Kapke and Yunhe Liu and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Jiang Xu

57 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiang Xu United States 27 988 718 264 233 216 60 1.9k
Scott P. Levick United States 25 1.2k 1.2× 637 0.9× 194 0.7× 251 1.1× 134 0.6× 54 2.2k
Yun-He Liu United States 21 1.1k 1.1× 594 0.8× 255 1.0× 265 1.1× 275 1.3× 23 1.9k
Hiromitsu Kanamori Japan 27 861 0.9× 1.0k 1.4× 189 0.7× 202 0.9× 172 0.8× 93 2.5k
Ping H. Wang United States 26 525 0.5× 1.1k 1.6× 261 1.0× 275 1.2× 113 0.5× 51 1.9k
Nour-Eddine Rhaleb United States 32 1.3k 1.3× 888 1.2× 351 1.3× 278 1.2× 332 1.5× 43 2.7k
Pamela Harding United States 28 614 0.6× 698 1.0× 274 1.0× 315 1.4× 71 0.3× 62 1.8k
Jianguo Jin United States 27 1.5k 1.5× 1.0k 1.4× 201 0.8× 184 0.8× 260 1.2× 49 3.5k
Peter P. Rainer Austria 27 1000 1.0× 1.0k 1.4× 256 1.0× 285 1.2× 73 0.3× 95 2.2k
Gen Takagi Japan 23 898 0.9× 996 1.4× 175 0.7× 240 1.0× 60 0.3× 57 2.0k
Chandi Griffin United States 26 951 1.0× 1.3k 1.8× 717 2.7× 193 0.8× 294 1.4× 48 2.6k

Countries citing papers authored by Jiang Xu

Since Specialization
Citations

This map shows the geographic impact of Jiang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang Xu more than expected).

Fields of papers citing papers by Jiang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang Xu. The network helps show where Jiang Xu may publish in the future.

Co-authorship network of co-authors of Jiang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang Xu. A scholar is included among the top collaborators of Jiang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang Xu. Jiang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Hongmei, et al.. (2025). Novel insights into beta cell ER stress CHOP and its role in HFpEF development. Cardiovascular Diabetology. 24(1). 250–250.
2.
Suhail, Hamid, Hongmei Peng, Jiang Xu, et al.. (2022). Knockout of ACE-N facilitates improved cardiac function after myocardial infarction. SHILAP Revista de lepidopterología. 3. 100024–100024. 2 indexed citations
3.
Sabbah, Hani N., Kefei Zhang, Ramesh C. Gupta, Jiang Xu, & Vinita Singh‐Gupta. (2020). Effects of Angiotensin-Neprilysin Inhibition in Canines with Experimentally Induced Cardiorenal Syndrome. Journal of Cardiac Failure. 26(11). 987–997. 12 indexed citations
4.
Wang, Yingge, Yaping Wang, Hongmei Chen, et al.. (2020). Activation of PPAR-β/δ Attenuates Brain Injury by Suppressing Inflammation and Apoptosis in a Collagenase-Induced Intracerebral Hemorrhage Mouse Model. Neurochemical Research. 45(4). 837–850. 22 indexed citations
5.
Venkat, Poornima, Chengcheng Cui, Zhili Chen, et al.. (2020). CD133+Exosome Treatment Improves Cardiac Function after Stroke in Type 2 Diabetic Mice. Translational Stroke Research. 12(1). 112–124. 37 indexed citations
6.
Sabbah, Hani N., Kefei Zhang, Jiang Xu, Ramesh C. Gupta, & Vinita Singh‐Gupta. (2017). Abstract 14139: Therapy With Sacubitril/Valsartan Improves Left Ventricular Systolic Function and Biomarkers of Kidney Injury in Dogs With Experimentally-Induced Cardiorenal Syndrome. Circulation. 1 indexed citations
7.
Chen, Jieli, Chengcheng Cui, Xiaoping Yang, et al.. (2017). MiR-126 Affects Brain-Heart Interaction after Cerebral Ischemic Stroke. Translational Stroke Research. 8(4). 374–385. 134 indexed citations
9.
Gupta, Ramesh C., Vinita Singh‐Gupta, Kefei Zhang, Jiang Xu, & Hani N. Sabbah. (2016). Abstract 12949: Elamipretide (BendaviaTM) Restores 4-Hydroxy-2-Nonenal Protein Adducts and Aldehyde Dehydrogenase-2 Activity and mRNA Expression in Left Ventricular Myocardium of Dogs With Advanced Heart Failure. Circulation. 1 indexed citations
10.
Xu, Jiang, et al.. (2013). Fractalkine Depresses Cardiomyocyte Contractility. PLoS ONE. 8(7). e69832–e69832. 16 indexed citations
11.
Xu, Hui, et al.. (2012). Sustainable Environment and Transportation. Applied Mechanics and Materials. 3 indexed citations
12.
Peng, Hongmei, Xiao-Ping Yang, Oscar A. Carretero, et al.. (2011). Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice. Experimental Physiology. 96(8). 756–764. 59 indexed citations
13.
Xu, Jiang, et al.. (2008). Dose‐dependent cardiac effect of oestrogen replacement in mice post‐myocardial infarction. Experimental Physiology. 93(8). 982–993. 29 indexed citations
14.
Liu, Yun-He, Dahai Wang, Nour-Eddine Rhaleb, et al.. (2005). Inhibition of p38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure resulting from myocardial infarction. Journal of Cardiac Failure. 11(1). 74–81. 58 indexed citations
15.
Dhalla, Arvinder K., et al.. (2004). 1170-142 Differential vasodilatory effects of CVT-3146, an A 2A adenosine receptor agonist in various vascular beds in anesthetized dogs. Journal of the American College of Cardiology. 43(5). A367–A368. 3 indexed citations
16.
Wang, Dahai, Yun-He Liu, Xiao-Ping Yang, et al.. (2004). Role of a selective aldosterone blocker in mice with chronic heart failure. Journal of Cardiac Failure. 10(1). 67–73. 34 indexed citations
17.
Xu, Jiang, Jian‐Fang Ren, Alessandro Mugelli, et al.. (2002). Age-Dependent Atrial Remodeling Induced by Recombinant Human Interleukin-11: Implications for Atrial Flutter/Fibrillation. Journal of Cardiovascular Pharmacology. 39(3). 435–440. 16 indexed citations
18.
Yang, Fang, Yunhe Liu, Xiaoping Yang, et al.. (2002). Myocardial Infarction and Cardiac Remodelling in Mice. Experimental Physiology. 87(5). 547–555. 155 indexed citations
19.
Liu, Yunhe, Jiang Xu, Xiaoping Yang, et al.. (2000). Cardiac Function in Endothelial Nitric Oxide Synthase Knockout Mice with Heart Failure. Hypertension. 36. 703–703. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026